Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MindBio Therapeutics Corp C.MBIO

MindBio Therapeutics Corp. is a biotech/biopharma company. It creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. It is focused on microdosing of psychedelic medicines and is advancing its drug and technology protocols through clinical trials. It develops a multi-disciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase 1 clinical trials in 80 healthy participants and has completed a Phase 2a clinical trial in patients with Major Depressive Disorder. The underway are two Phase 2B trials, one in cancer patients experiencing existential distress and another in patients with Major Depressive Disorder. It invests in research that forms the basis for developing novel and clinically proven treatments.


CSE:MBIO - Post by User

Post by Dude51on Oct 14, 2023 1:05pm
148 Views
Post# 35683732

Here's a quote from Marijuana Moment:

Here's a quote from Marijuana Moment:"Interestingly, the officials also cited research suggesting that marijuana is “more addictive than several other Schedule I drugs, including LSD, GHB, ecstasy, and khat,” though they did not suggest that those substances should be rescheduled, despite FDA designating MDMA (or ecstasy) a breakthrough therapy that some expect to receive federal approval as a medication as early as next year."

So there going to recieve FDA approval MDMA(ecstasy) blah blah blah. Just wait till the results of our phase 2 results hit the internet in about a month or two. Just another nail in the coffin of the conservative talking points about the evils of marijuana.

All the states have to do is look to Canada. The only problem that I have heard of 5 years after legalization in Canada is that there are stupid people that smoke pot. I am talking about the idiots who some how manage to drop their pot on the ground and some dog comes along sniffs then eats it.
That is the only issue that I have heard about if someone can name another one I am all eyes.

GL


<< Previous
Bullboard Posts
Next >>